Lilly Diabetes Launches Android Version of Glucagon Mobile Application for Those Who Support People with Diabetes
App serves as a teaching tool and can help you prepare for treatment with Lilly Glucagon for Injection (rDNA origin) during a severe low blood sugar episode
INDIANAPOLIS, July 14, 2015 /PRNewswire/ --
- Now for Android: Lilly Diabetes' Glucagon Mobile App to support #diabetes caregivers
- Leverage the power of Android or iPhone technology through the Lilly Glucagon Mobile App for people with #diabetes
- Help be prepared for a severe #diabetes low blood sugar episode with the Lilly Glucagon Mobile App for Android or iPhone
Lilly Diabetes has released an Android version of its mobile application designed for caregivers and healthcare providers who support people with diabetes. Through an injection tutorial and emergency instructions, the App can help people practice the injection steps ahead of time, which may help them feel better prepared to assist. Other features of the App include a kit location log, so kits can be easily located during an emergency, and an expiration date log that sends a reminder when a kit is getting close to its expiration date, so a new kit can be obtained before this date.
Glucagon is a treatment for insulin coma or insulin reaction resulting from severe low blood sugar. Glucagon should not be used if you have pheochromocytoma or if you are allergic to Glucagon.
The Lilly Glucagon Mobile App for Android mobile devices is available as a free download on Google Play TM. It has been available on the iTunes® store as a free download for Apple mobile devices since September 2012.
"Lilly Diabetes is committed to developing personalized solutions to help people with diabetes achieve their treatment goals and improve their outcomes—including the creation of innovative online tools that provide a range of support," said Matt Caffrey, senior director, consumer marketing, Lilly Diabetes. "The new version of the Lilly Glucagon Mobile App leverages the power of Android mobile technology, helping us reach even more caregivers and providing another opportunity to support people living with type 1 diabetes."
Important Safety Information for Glucagon
What is the most important information I should know about Glucagon?
- Glucagon should not be used if you have pheochromocytoma or if you are allergic to Glucagon.
- Make sure you tell your healthcare provider if you have been diagnosed with or have been suspected of having an insulinoma as Glucagon should be used cautiously in this situation.
- You and anyone who may need to help you during an emergency should become familiar with how to use Glucagon before an emergency arises. Read the Information for the User provided in the kit.
- Make sure that your relatives or close friends know that if you become unconscious, medical assistance must always be sought. If you are unconscious, Glucagon can be given while awaiting medical assistance.
- Do not use the kit after the date stamped on the bottle label.
- If you have questions concerning the use of this product, consult a doctor, nurse or pharmacist.
WARNING: YOU MAY BE IN A COMA FROM SEVERE HYPERGLYCEMIA (HIGH BLOOD GLUCOSE) RATHER THAN HYPOGLYCEMIA. IN SUCH A CASE, YOU WILL NOT RESPOND TO GLUCAGON AND REQUIRE IMMEDIATE MEDICAL ATTENTION.
Who should not use Glucagon?
Glucagon should not be used if you have pheochromocytoma or if you are allergic to Glucagon.
What should I tell my doctor before taking Glucagon?
Tell your doctor about all of your medical conditions and prescription and over-the-counter drugs. Tell your doctor if you have been diagnosed with or have been suspected of having pheochromocytoma or an insulinoma.
How should I use Glucagon?
- Act quickly. Prolonged unconsciousness may be harmful.
- Make sure your family and friends know to turn you on your side to prevent choking if you are unconscious.
- The contents of the syringe are inactive and must be mixed with the Glucagon in the accompanying bottle immediately before giving injection. Do not prepare Glucagon for Injection until you are ready to use it.
- Glucagon should not be used unless the solution is clear and of a water-like consistency.
- The usual adult dose is 1 mg (1 unit). For children weighing less than 44 lbs (20 kg), give ½ adult dose (0.5 mg). For children, withdraw ½ of the solution from the bottle (0.5 mg mark on syringe). Discard unused portion.
- You should eat as soon as you awaken and are able to swallow. Inform a doctor or emergency services immediately.
What is some important Information I should know about Low Blood Sugar (Hypoglycemia)?
- Early symptoms of low blood sugar include: sweating, drowsiness, dizziness, sleep disturbances, palpitation, anxiety, tremor, blurred vision, hunger, slurred speech, restlessness, depressed mood, tingling in the hands, feet, lips, or tongue, irritability, lightheadedness, abnormal behavior, inability to concentrate, unsteady movement, headache, and personality changes. These symptoms may be different for each person and can happen suddenly.
- If your low blood sugar is not treated, you may progress to severe low blood sugar that can include: disorientation, seizures, unconsciousness, and death.
- Low blood sugar symptoms should be treated with a quick source of sugar which should always be carried with you. If you do not improve or you are unable to take a quick source of sugar, you should be treated with Glucagon or with intravenous glucose at a medical facility.
What are the possible side effects of Glucagon?
- Severe side effects are very rare, although nausea and vomiting may occur occasionally.
- A few people may be allergic to Glucagon or to one of the inactive ingredients in Glucagon, or may experience rapid heart beat for a short while.
- If you experience any other reactions which are likely to have been caused by Glucagon, please contact your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
How should I store Glucagon?
- Before dissolving Glucagon with diluting solution, store the kit at controlled room temperature between 20° to 25°C (68° to 77°F).
- After dissolving Glucagon with diluting solution, use immediately. Discard any unused portion. Glucagon should be clear and of a water-like consistency at time of use.
Glucagon is available by prescription only.
For more safety information, please see Information for the User and Information for the Physician.
HI GLUC CON ISI 09OCT2014
About Lilly Diabetes
Lilly has been a global leader in diabetes care since 1923, when we introduced the world's first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research and collaboration, a broad and growing product portfolio, and a continued determination to provide real solutions—from medicines to support programs and more—we strive to make life better for all those affected by diabetes around the world. For more information, visit www.lillydiabetes.com and follow @LillyDiabetes on Twitter.
About Eli Lilly and Company (NYSE: LLY)
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and newsroom.lilly.com/social-channels.
LD96226 04/2015 ©Lilly USA, LLC 2015. All rights reserved.
Refer to: 317-627-4056; [email protected]; Julie Herrick Williams, Lilly Diabetes
Google Play TM, a registered trademark of Google, Inc.
iTunes® is a registered trademark of Apple, Inc.
Logo - http://photos.prnewswire.com/prnh/20031219/LLYLOGO
SOURCE Eli Lilly and Company